Skip to main content
NurPhoto Agency Logo
  • Home
  • Editorial Pictures
    • Unrest, Conflicts and War
    • Arts, Culture and Entertainment
    • Sports

    • All Categories

    • Latest Galleries
  • Reportage
  • News of the Week
  • Videos
  • (0)
  • Login
  • Register

Search Editorial Photos

Enter keywords to search our editorial photo archive
  1. Home
  2. Search
  3. clinical effectiveness

Refine Results

Active Filters:
Sort By
Content Type
Location
People

"clinical effectiveness"

26 professional editorial images found

Loading search results...
ADHD medication is seen in this illustration photo taken in Warsaw, Poland on 15 January, 2025. (Photo by Jaap Arriens/NurPhoto)

#11948533

Challenges In The Global ADHD Medication Supply Chain

15 January 2025

ADHD medication is seen in this illustration photo taken in Warsaw, Poland on 15 January, 2025. (Photo by Jaap Arriens/NurPhoto)

#11948533

15 January 2025

ADHD medication is seen in this illustration photo taken in Warsaw, Poland on 15 January, 2025.


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is consider...

#10798144

Germany To Ban Export Of Ozempic Weight Loss Drug

19 November 2023

A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is consider...

#10798144

19 November 2023

A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is consider...

#10798140

Germany To Ban Export Of Ozempic Weight Loss Drug

19 November 2023

A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is consider...

#10798140

19 November 2023

A woman holds an Ozempic needle shot pen in this photograph taken in Warsaw, Poland on 19 November, 2023. German regulator BfArM is considering banning the export of the Ozempic weight loss drug, manufactured by the Danish Novo Nordisk company due to shortages caused by popularity in the United States. Ozempic is commonly prescribed to patience with diabetes or a risk or getting diabetes however Ozempic is also effective as a stand alone weight loss solution.


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274256

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274256

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274258

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274258

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274260

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274260

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274262

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274262

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274264

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274264

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274266

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274266

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274270

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274270

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274272

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274272

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274274

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274274

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274276

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274276

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274278

Illustration Of Moderna Logo With A Syringe

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the Amer...

#6274278

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled ou...

#6269082

Illustration Of Pfizer Logo With A Syringe

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled ou...

#6269082

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled ou...

#6269084

Illustration Of Pfizer Logo With A Syringe

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled ou...

#6269084

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020


Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.


of 2
Next
NurPhoto Logo

Independent photojournalistic agency delivering global visual storytelling since 2013. Trusted by leading media organizations worldwide.

Company
  • About Us
  • Work With Us
  • Contact Us
  • Reportages
Services
  • Editorial Pictures
  • Assignments
  • Research Services
  • Fine Art Prints
  • Creative Content
Resources
  • License Terms
  • Terms of Service
  • Privacy Policy
  • Support Center
Connect With Us
[email protected]
24/7 Support
Follow Our Stories

© 2013-2026 NurPhoto S.r.l. All rights reserved. | VAT IT01921690663

We accept:
Click outside this window to close it